# Remifentanil in Adults With OSA

> **NCT02898792** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 77 (actual)

## Conditions studied

- Apnea, Sleep

## Interventions

- **DRUG:** Targeted infusion of remifentanil

## Key facts

- **NCT ID:** NCT02898792
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-16
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2018-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02898792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02898792, "Remifentanil in Adults With OSA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02898792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*